Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 075117
Company: CONCORDIA PHARMS INC
Company: CONCORDIA PHARMS INC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ORAPRED | PREDNISOLONE SODIUM PHOSPHATE | EQ 15MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
12/14/2000 | ORIG-1 | Approval |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/75-117_Orapred_prntlbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/75117ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/75-117_Orapred.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
06/16/2005 | SUPPL-12 | Labeling |
Label is not available on this site. |
||
11/07/2002 | SUPPL-6 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
05/08/2002 | SUPPL-5 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
08/28/2001 | SUPPL-4 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
08/28/2001 | SUPPL-3 | Manufacturing (CMC)-Facility |
Label is not available on this site. |
||
06/25/2001 | SUPPL-2 | Manufacturing (CMC)-Facility |
Label is not available on this site. |
||
03/28/2001 | SUPPL-1 | Manufacturing (CMC) |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
12/14/2000 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/75-117_Orapred_prntlbl.pdf |